List Results
Refine Search
Results by Topic
Results on Map
Search Details
Found 750 studies with search of: "Hodgkin Disease"
Hide studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Recruiting Gemcitabine and Hodgkin's Disease Chemotherapy Followed by Peripheral Blood Stem Cell Rescue for Hodgkin's Disease
Conditions: Lymphoma;   Lymphoma, Hodgkin Disease;   Hodgkin Disease
Interventions: Drug: Gemcitabine;   Drug: Vinorelbine;   Drug: Carmustine;   Drug: Etoposide;   Drug: Cyclophosphamide;   Procedure: Autologous hematopoietic stem cell transplantation.
2 Not yet recruiting Massage Therapy Given by Caregiver in Treating Quality of Life of Young Patients Undergoing Treatment for Cancer
Conditions: Unspecified Childhood Solid Tumor, Protocol Specific;   Accelerated Phase Chronic Myelogenous Leukemia;   Acute Undifferentiated Leukemia;   Angioimmunoblastic T-cell Lymphoma;   Atypical Chronic Myeloid Leukemia;   Blastic Phase Chronic Myelogenous Leukemia;   Burkitt Lymphoma;   Childhood Acute Lymphoblastic Leukemia in Remission;   Childhood Acute Myeloid Leukemia in Remission;   Childhood Chronic Myelogenous Leukemia;   Childhood Diffuse Large Cell Lymphoma;   Childhood Grade III Lymphomatoid Granulomatosis;   Childhood Immunoblastic Large Cell Lymphoma;   Childhood Myelodysplastic Syndromes;   Childhood Nasal Type Extranodal NK/T-cell Lymphoma;   Chronic Eosinophilic Leukemia;   Chronic Idiopathic Myelofibrosis;   Chronic Myelomonocytic Leukemia;   Chronic Neutrophilic Leukemia;   Chronic Phase Chronic Myelogenous Leukemia;   Contiguous Stage II Mantle Cell Lymphoma;   Cutaneous B-cell Non-Hodgkin Lymphoma;   Essential Thrombocythemia;   Extramedullary Plasmacytoma;   Intraocular Lymphoma;   Isolated Plasmacytoma of Bone;   Juvenile Myelomonocytic Leukemia;   Mast Cell Leukemia;   Meningeal Chronic Myelogenous Leukemia;   Noncontiguous Stage II Mantle Cell Lymphoma;   Polycythemia Vera;   Post-transplant Lymphoproliferative Disorder;   Primary Systemic Amyloidosis;   Progressive Hairy Cell Leukemia, Initial Treatment;   Prolymphocytic Leukemia;   Recurrent Childhood Acute Lymphoblastic Leukemia;   Recurrent Childhood Acute Myeloid Leukemia;   Recurrent Childhood Anaplastic Large Cell Lymphoma;   Recurrent Childhood Grade III Lymphomatoid Granulomatosis;   Recurrent Childhood Large Cell Lymphoma;   Recurrent Childhood Lymphoblastic Lymphoma;   Recurrent Childhood Small Noncleaved Cell Lymphoma;   Recurrent Cutaneous T-cell Non-Hodgkin Lymphoma;   Recurrent Mycosis Fungoides/Sezary Syndrome;   Recurrent/Refractory Childhood Hodgkin Lymphoma;   Refractory Chronic Lymphocytic Leukemia;   Refractory Hairy Cell Leukemia;   Refractory Multiple Myeloma;   Relapsing Chronic Myelogenous Leukemia;   Secondary Acute Myeloid Leukemia;   Stage 0 Chronic Lymphocytic Leukemia;   Stage I Childhood Anaplastic Large Cell Lymphoma;   Stage I Childhood Hodgkin Lymphoma;   Stage I Childhood Large Cell Lymphoma;   Stage I Childhood Lymphoblastic Lymphoma;   Stage I Childhood Small Noncleaved Cell Lymphoma;   Stage I Chronic Lymphocytic Leukemia;   Stage I Cutaneous T-cell Non-Hodgkin Lymphoma;   Stage I Multiple Myeloma;   Stage I Mycosis Fungoides/Sezary Syndrome;   Stage II Childhood Anaplastic Large Cell Lymphoma;   Stage II Childhood Hodgkin Lymphoma;   Stage II Childhood Large Cell Lymphoma;   Stage II Childhood Lymphoblastic Lymphoma;   Stage II Childhood Small Noncleaved Cell Lymphoma;   Stage II Chronic Lymphocytic Leukemia;   Stage II Cutaneous T-cell Non-Hodgkin Lymphoma;   Stage II Multiple Myeloma;   Stage II Mycosis Fungoides/Sezary Syndrome;   Stage III Childhood Anaplastic Large Cell Lymphoma;   Stage III Childhood Hodgkin Lymphoma;   Stage III Childhood Large Cell Lymphoma;   Stage III Childhood Lymphoblastic Lymphoma;   Stage III Childhood Small Noncleaved Cell Lymphoma;   Stage III Chronic Lymphocytic Leukemia;   Stage III Cutaneous T-cell Non-Hodgkin Lymphoma;   Stage III Multiple Myeloma;   Stage III Mycosis Fungoides/Sezary Syndrome;   Stage IV Childhood Anaplastic Large Cell Lymphoma;   Stage IV Childhood Hodgkin Lymphoma;   Stage IV Childhood Large Cell Lymphoma;   Stage IV Childhood Lymphoblastic Lymphoma;   Stage IV Childhood Small Noncleaved Cell Lymphoma;   Stage IV Chronic Lymphocytic Leukemia;   Stage IV Cutaneous T-cell Non-Hodgkin Lymphoma;   Stage IV Mycosis Fungoides/Sezary Syndrome;   T-cell Large Granular Lymphocyte Leukemia
Interventions: Procedure: massage therapy;   Other: questionnaire administration;   Procedure: quality-of-life assessment;   Other: intervention by caregiver;   Procedure: standard follow-up care
3 Active, not recruiting Phase II Study of Lenalidomide for the Treatment of Relapsed or Refractory Hodgkin's Lymphoma
Condition: Hodgkin Disease
Intervention: Drug: Lenalidomide (Revlimid®)
4 Terminated Study of Bortezomib (Velcade) in Combination With Dexamethasone to Treat Patients With Relapsed Hodgkin's Lymphoma
Condition: Hodgkin Disease
Interventions: Drug: Bortezomib;   Drug: Dexamethasone
5 Recruiting A Phase II Study of IGEV +/- Bortezomib Before Hign Dose Consolidation in Relapsed/Refractory Hodgkin's Lymphoma
Condition: Hodgkin Disease
Interventions: Drug: Ifosfamide, Gemcitabine, Vinorelbine;   Drug: Bortezomib + IGEV
6 Recruiting Optimization of the Primary Therapy for Patients With Hodgkin's Disease and Evaluation of PET
Condition: Hodgkin Disease
Interventions: Drug: Combined chemotherapy (ABVD, BACOPP-D);   Procedure: Radiation therapy
7 Recruiting Lenalidomide in Relapsed or Refractory Classical Hodgkin Lymphoma
Condition: Hodgkin Disease
Interventions: Drug: Lenalidomide;   Drug: lenalidomide
8 Not yet recruiting Safety, Pharmacokinetics and Stem Cell Mobilization of TG-0054 in Multiple Myeloma, Non-Hodgkin Lymphoma and Hodgkin Disease Patients
Conditions: Multiple Myeloma;   Non-Hodgkin Lymphoma;   Hodgkin Disease
Intervention: Drug: TG-0054
9 Not yet recruiting Evaluation of Late Treatment Effects in Long-Term Survivors of Hodgkin's Disease Previously Treated at NIH: A Multi-Institutional Trial
Conditions: Hodgkin's Disease;   Lymphoma
Intervention:
10 Not yet recruiting Study Comparing Rituximab and a Combination of ABVD in Hodgkin's Disease
Condition: Hodgkin's Disease
Interventions: Drug: Rituximab;   Drug: ABVD
11 Completed Phase II Study of Filgrastim (G-CSF) Plus ABVD in the Treatment of HIV-Associated Hodgkin's Disease
Conditions: HIV Infections;   Hodgkin's Disease
Interventions: Drug: Vinblastine sulfate;   Drug: Dacarbazine;   Drug: Filgrastim;   Drug: Bleomycin sulfate;   Drug: Doxorubicin hydrochloride
12 Recruiting Allogeneic Blood Stem Cell Transplantation and Adoptive Immunotherapy for Hodgkin's Disease
Condition: Hodgkin's Disease
Interventions: Drug: Gemcitabine;   Drug: Fludarabine;   Drug: Melphalan;   Drug: Antithymocyte Globulin;   Procedure: Allogeneic Stem Cell Infusion
13 Terminated Phase II Trial of Thalidomide in Refractory/Relapsed Diffuse Large B-Cell Lymphoma and Hodgkin's Disease
Conditions: B-Cell Lymphoma;   Hodgkin's Disease
Intervention: Drug: Thalidomide
14 Completed Mantle Irradiation for Hodgkin's Disease
Condition: Hodgkin's Disease
Intervention: Procedure: Mantle irradiation
15 Completed AMD3100 Added to a Mobilizing Regimen of G-CSF to Increase the Number of PBSCs in Patients With Hodgkin's Disease
Condition: Hodgkin's Disease
Intervention: Drug: AMD3100
16 Terminated
Has Results 		Alemtuzumab (Campath-1H) Monoclonal Antibody in Patients With Relapsed and Resistant Classical Hodgkin's Disease
Conditions: Hodgkin's Disease;   Lymphoma
Intervention: Drug: Alemtuzumab (Campath-1H)
17 Completed A Phase II Study of MDX-060 in Subjects With Relapsed or Refractory Hodgkin's Disease
Condition: Hodgkin's Disease
Intervention: Drug: MDX-060
18 Terminated Combination Chemotherapy +/- Radiation in High Risk Hodgkin's Disease
Condition: Hodgkin Disease
Intervention: Drug: doxorubicin,vinblastine,cyclophosphamide,etoposide,vincristine,bleomycin,gemcitabine,vinorelbine,prednisone
19 Active, not recruiting Tamoxifen in the Prevention of Breast Cancer in Hodgkin's Disease Survivors
Conditions: Hodgkin's Disease;   Breast Cancer
Intervention: Drug: Tamoxifen
20 Recruiting Prediction of the Response to Chemotherapy by Tomoscintigraphie the MIBI in the Balance Sheet Pre Hodgkin's Disease and Lymphoma Malins High Grade
Conditions: Hodgkin's Disease;   Malignant Lymphomas High Grade;   Chemoresistance
Intervention: Procedure: TEP au MIBI

Previous Page Studies Shown (1-20) Next Page (21-40)
Save this search by bookmarking this page.
When you use your bookmark, the search will be performed again on the most recent collection of studies.
RSS Feeds for studies found by your search that were:
  First received in the last 14 days,  
  Last updated (includes received) in the last 30 days
  Download Options




Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services